Berkeley HeartLab sold to Celera for $195M

September 4, 2007 | David P. Hamilton | Comments | |

See our story on this Burlingame, Calif., diagnostics company in today’s daily briefing at VentureBeat Life Sciences. (UPDATE: The company’s name has been corrected in headline.)

Next Story: Hank Plain joins Morgenthaler Ventures
Previous Story: Life sciences briefing: Tuesday, Sept. 4, 2007

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.